IS7 Fundamental Analysis - INTICA SYSTEMS SE

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to IS7. IS7 was compared to 56 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of IS7 have multiple concerns. IS7 does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IS7 has reported negative net income.

In the past year IS7 had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: IS7 reported negative net income in multiple years.

IS7 had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

IS7 has a worse Return On Assets (-7.00%) than 71.43% of its industry peers.

IS7 has a Return On Equity of -24.64%. This is in the lower half of the industry: IS7 underperforms 69.64% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7%
ROE	-24.64%
ROIC	N/A

ROA(3y)-1.02%

ROA(5y)0.02%

ROE(3y)-3.67%

ROE(5y)-0.35%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of IS7 has declined.

IS7 has a Gross Margin (43.37%) which is comparable to the rest of the industry.

In the last couple of years the Gross Margin of IS7 has remained more or less at the same level.

IS7 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	43.37%

OM growth 3Y-45.56%

OM growth 5Y-27.46%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.66%

GM growth 5Y1.46%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IS7 does not have a ROIC to compare to the WACC, probably because it is not profitable.

IS7 has about the same amout of shares outstanding than it did 1 year ago.

IS7 has about the same amout of shares outstanding than it did 5 years ago.

IS7 has a worse debt/assets ratio than last year.

2.2 Solvency

IS7 has an Altman-Z score of 0.99. This is a bad value and indicates that IS7 is not financially healthy and even has some risk of bankruptcy.

IS7 has a worse Altman-Z score (0.99) than 82.14% of its industry peers.

IS7 has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as IS7 would need 3.86 years to pay back of all of its debts.

IS7's Debt to FCF ratio of 3.86 is fine compared to the rest of the industry. IS7 outperforms 62.50% of its industry peers.

IS7 has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.

IS7's Debt to Equity ratio of 0.34 is in line compared to the rest of the industry. IS7 outperforms 55.36% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.34
Debt/FCF	3.86
Altman-Z	0.99

ROIC/WACCN/A

WACC6.03%

2.3 Liquidity

A Current Ratio of 0.84 indicates that IS7 may have some problems paying its short term obligations.

The Current ratio of IS7 (0.84) is worse than 87.50% of its industry peers.

A Quick Ratio of 0.42 indicates that IS7 may have some problems paying its short term obligations.

IS7's Quick ratio of 0.42 is on the low side compared to the rest of the industry. IS7 is outperformed by 89.29% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.84
Quick Ratio	0.42

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for IS7 have decreased strongly by -178.66% in the last year.

The Revenue for IS7 has decreased by -18.91% in the past year. This is quite bad

Measured over the past years, IS7 shows a small growth in Revenue. The Revenue has been growing by 1.44% on average per year.

EPS 1Y (TTM)-178.66%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-200%

Revenue 1Y (TTM)-18.91%

Revenue growth 3Y-9.65%

Revenue growth 5Y1.44%

Sales Q2Q%-10.33%

3.2 Future

Based on estimates for the next years, IS7 will show a very strong growth in Earnings Per Share. The EPS will grow by 36.68% on average per year.

IS7 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.82% yearly.

EPS Next Y10.71%

EPS Next 2Y36.28%

EPS Next 3Y36.68%

EPS Next 5YN/A

Revenue Next Year-2.27%

Revenue Next 2Y1.76%

Revenue Next 3Y3.82%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IS7 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IS7. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IS7 indicates a somewhat cheap valuation: IS7 is cheaper than 71.43% of the companies listed in the same industry.

IS7's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IS7 is cheaper than 98.21% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	1.28
EV/EBITDA	7.44

4.3 Compensation for Growth

A more expensive valuation may be justified as IS7's earnings are expected to grow with 36.68% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y36.28%

EPS Next 3Y36.68%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IS7!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

INTICA SYSTEMS SE

FRA:IS7 (10/17/2025, 7:00:00 PM)

2.03

-0.03 (-1.46%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryElectronic Equipment, Instruments & Components

Earnings (Last)08-08 2025-08-08

Earnings (Next)11-25 2025-11-25

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners60.42%

Ins Owner ChangeN/A

Market Cap8.71M

Analysts45.71

Price Target3.67 (80.79%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-5.26%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-19.05%

EPS NY rev (3m)-56.25%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-6.5%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.13
P/FCF	1.28
P/OCF	0.96
P/B	0.55
P/tB	0.79
EV/EBITDA	7.44

EPS(TTM)-0.94

EYN/A

EPS(NY)-0.08

Fwd EYN/A

FCF(TTM)1.59

FCFY78.22%

OCF(TTM)2.11

OCFY104.05%

SpS15.3

BVpS3.72

TBVpS2.58

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7%
ROE	-24.64%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	43.37%
FCFM	10.38%

ROA(3y)-1.02%

ROA(5y)0.02%

ROE(3y)-3.67%

ROE(5y)-0.35%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)1.7%

ROCE(5y)3.73%

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-45.56%

OM growth 5Y-27.46%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.66%

GM growth 5Y1.46%

F-Score4

Asset Turnover1.17

Health

		Industry Rank	Sector Rank
Debt/Equity	0.34
Debt/FCF	3.86
Debt/EBITDA	1.26
Cap/Depr	34.08%
Cap/Sales	3.43%
Interest Coverage	N/A
Cash Conversion	211.31%
Profit Quality	N/A
Current Ratio	0.84
Quick Ratio	0.42
Altman-Z	0.99

F-Score4

WACC6.03%

ROIC/WACCN/A

Cap/Depr(3y)103.63%

Cap/Depr(5y)82.04%

Cap/Sales(3y)7.51%

Cap/Sales(5y)5.88%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-178.66%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-200%

EPS Next Y10.71%

EPS Next 2Y36.28%

EPS Next 3Y36.68%

EPS Next 5YN/A

Revenue 1Y (TTM)-18.91%

Revenue growth 3Y-9.65%

Revenue growth 5Y1.44%

Sales Q2Q%-10.33%

Revenue Next Year-2.27%

Revenue Next 2Y1.76%

Revenue Next 3Y3.82%

Revenue Next 5YN/A

EBIT growth 1Y-992.66%

EBIT growth 3Y-50.82%

EBIT growth 5Y-26.41%

EBIT Next Year1083.33%

EBIT Next 3Y150.22%

EBIT Next 5YN/A

FCF growth 1Y269.96%

FCF growth 3YN/A

FCF growth 5Y-9.62%

OCF growth 1Y43.35%

OCF growth 3Y29.25%

OCF growth 5Y-6.33%

INTICA SYSTEMS SE (IS7.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens